Drug – bio-affecting and body treating compositions – Arthritis
Patent
1994-09-28
1998-03-03
Seidleck, James J.
Drug, bio-affecting and body treating compositions
Arthritis
424 931, 424 9371, 424534, A06N 6300
Patent
active
057235031
ABSTRACT:
A method of treating rheumatoid arthritis is provided which involves administering an effective amount of allogeneic mononuclear cells or a molecule derived from these cells to an individual having rheumatoid arthritis. Also provided are compositions for the treatment of rheumatoid arthritis.
REFERENCES:
patent: 4996194 (1991-02-01), Cohen et al.
patent: 5114721 (1992-05-01), Cohen et al.
patent: 5239062 (1993-08-01), Blattler et al.
patent: 5304474 (1994-04-01), Lipsky et al.
patent: 5316763 (1994-05-01), Ochoa et al.
Elliott et al., "Treatment of Rheumatoid Arthritis with Chimeric Monoclonal Antibodies to Tumor Necrosis Factor .alpha.," Arthritis Rheum., 36:1681-1690, 1993.
Goldberg et al., "Immunological Effects of High Dose Administration of Anti-CD4 Antibody in Rheumatoid Arthritis Patients," J. Autoimmun., 4:617-630, 1991.
Herzog et al., "Anti-CD4 Antibody Treatment of Patients with Rheumatoid Arthritis: I. Effect on Clinical Course and Circulating T Cells," J. Autoimmun., 2:627-642, 1989.
Horneff et al., "Treatment of Rheumatoid Arthritis with an Anti-CD4 Monoclonal Antibody," Arthritis Rheum., 34:129-140, 1991.
Karsh et al., "Lymphapheresis in Rheumatoid Arthritis," Arthritis Rheum., 24:867-873, 1981.
Kingsley et al., "T Cell Vaccination in Humans," Clinical & Exp. Rheum., 11 (suppl. 8):S63-S64, 1993.
Lohse et al., "Induction of an Anti-vaccine Response by T Cell Vaccination in Non-human Primates and Humans, " J. Autoimmun., 1:121-130, 1993.
Moreland et al., "Use of a Chimeric Monoclonal Anti-CD4 Antibody in Patients with Refractory Rheumatoid Arthritis," Arthritis Rheum., 36:307-318, 1993.
Nelson et al., "Maternal-Fetal Disparity in HLA Class II Alloantigens and the Pregnancy-Induced Amelioration of Rheumatoid Arthritis," N. Engl. J. Med., 329:466-471, 1993.
Paulus et al., "Lymphocyte Involvement in Rheumatoid Arthritis," Arthritis Rheum, 20:1249-1262, 1977.
Persellin, R.H., "The Effect of Pregnancy on Rheumatoid Arthritis," Bul. Rheum. Dis, 27:922-927, 1977.
Reiter et al., "Treatment of Rheumatoid Arthritis with Monoclonal CD4 Antibody M-T151," Arthritis Rheum., 34:525-536, 1991.
Sany et al., "Immunomodulating Effect of Human Placenta-Eluted Gamma Globulins in Rheumatoid Arthritis," Arthritis Rheum., 25:17-24, 1982.
Strand et al., "Effects of Administration of An Anti-CD5 Plus Immunoconjugate in Rheumatoid Arthritis," Arthritis Rheum., 36:620-630, 1993.
Trentham et al., "Clinical and Immunologic Effects of Fractionated Total Lymphoid Irradiation in Refractory Rheumatoid Arthritis," N. Eng. J. Med., 305:976-982, 1981.
Tumiati et al., "High-Dose Immunoglobulin Therapy as an Immunomodulatory Treatment of Rheumatoid Arthritis," Arthritis Rheum., 35:1126-1133, 1992.
van Laar et al., "Effects of Inoculation with Attenuated Autologous T Cells in Patients with Rheumatoid Arthritis" J. Autoimmun., 6:159-167, 1993.
Wallace et al., "Plasmaphersis and Lymphoplasmapheresis in the Management of Rheumatoid Arthritis," Arthritis Rheum., 22:703-710, 1979.
Fort John G.
Smith J. Bruce
Seidleck James J.
Thomas Jefferson University
Williamson Michael A.
LandOfFree
Biological treatment for rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biological treatment for rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biological treatment for rheumatoid arthritis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2248181